Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 1/2016

01-02-2016

Health care access and smoking cessation among cancer survivors: implications for the Affordable Care Act and survivorship care

Published in: Journal of Cancer Survivorship | Issue 1/2016

Login to get access

Abstract

Purpose

The study objectives are to examine prevalence of current smoking, and to assess the association of both health insurance (HI) and access to care with smoking cessation among cancer survivors.

Methods

We performed an analysis from a cross-sectional study of cancer survivors aged 18–64 years using nationally representative data from the 2009 Behavioral Risk Factor Surveillance System survey. We assessed the prevalence of current smoking among cancer survivors. Also, in a subset excluding never smokers, we assessed cessation status of cancer survivors operationalized as comparing current to former smokers.

Results

The study population (N = 18,896) was predominantly 45–64 years of age, female, and white. The prevalence of current smoking was substantially greater among cancer survivors without HI (40.9 %) than for those with HI (19.5 %). Cancer survivors with no HI had 2-fold greater adjusted odds of not quitting cigarette smoking compared to those with HI. Among those with insurance, cancer survivors who did not have regular health care provider or could not see doctor due to cost or had their last routine checkup ≥1 year ago had 60–80 % fold greater adjusted odds of not quitting cigarette smoking compared to cancer survivors who had better access to health care.

Conclusions

Cancer survivors without HI have substantially greater current smoking rates compared with those with HI. Among cancer survivors with HI, those who experienced health care access-related problems had lower cessation rates than their counterparts.

Implications for Cancer Survivors

Smoking cessation needs to be recognized as a crucial component of preventive care for cancer survivors. Continuous patient engagement and cancer-patient-centered strategies are urgently needed to achieve optimal results for quit rates particularly for young cancer survivors who are most susceptible to current smoking.
Literature
1.
2.
3.
Holford TR, Meza R, Warner KE, Meernik C, Jeon J, Moolgavkar SH, et al. Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. JAMA. 2014;311(2):164–71.PubMedPubMedCentralCrossRef
4.
Jha P, Peto R. Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med. 2014;370(1):60–8.PubMedCrossRef
5.
Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA. 2014;311(2):183–92.PubMedCrossRef
6.
Schroeder SA, Koh HK. Tobacco control 50 years after the 1964 surgeon general’s report. JAMA. 2014;311(2):141–3.PubMedCrossRef
7.
8.
Agaku IT, King BA, Dube SR. Current cigarette smoking among adults—United States, 2005-2012. MMWR Morb Mortal Wkly Rep. 2014;63(2):29–34.PubMed
9.
US Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310(6):591–608.CrossRef
10.
Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291(10):1238–45.PubMedCrossRef
11.
Kiefe CI, Williams OD, Greenlund KJ, Ulene V, Gardin JM, Raczynski JM. Health care access and seven-year change in cigarette smoking. The CARDIA Study. Am J Prev Med. 1998;15(2):146–54.PubMedCrossRef
12.
Kiefe CI, Williams OD, Lewis CE, Allison JJ, Sekar P, Wagenknecht LE. Ten-year changes in smoking among young adults: are racial differences explained by socioeconomic factors in the CARDIA study? Am J Public Health. 2001;91(2):213–8.PubMedPubMedCentralCrossRef
13.
de Moor JS, Mariotto AB, Parry C, Alfano CM, Padgett L, Kent EE, et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev. 2013;22(4):561–70.PubMedPubMedCentralCrossRef
14.
15.
Clair C, Rigotti NA, Porneala B, Fox CS, D’Agostino RB, Pencina MJ, et al. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA. 2013;309(10):1014–21.PubMedPubMedCentralCrossRef
16.
Des Rochers C, Dische S, Saunders MI. The problem of cigarette smoking in radiotherapy for cancer in the head and neck. Clin Oncol (R Coll Radiol). 1992;4(4):214–6.PubMedCrossRef
17.
Ehdaie B, Furberg H, Zabor EC, Hakimi AA, Russo P. Comprehensive assessment of the impact of cigarette smoking on survival of clear cell kidney cancer. J Urol. 2014;191(3):597–602.PubMedPubMedCentralCrossRef
18.
Klosky JL, Tyc VL, Garces-Webb DM, Buscemi J, Klesges RC, Hudson MM. Emerging issues in smoking among adolescent and adult cancer survivors: a comprehensive review. Cancer. 2007;110(11):2408–19.PubMedCrossRef
19.
Tabuchi T, Ito Y, Ioka A, Nakayama T, Miyashiro I, Tsukuma H. Tobacco smoking and the risk of subsequent primary cancer among cancer survivors: a retrospective cohort study. Ann Oncol. 2013;24(10):2699–704.PubMedCrossRef
20.
Thompson TL, Pagedar NA, Karnell LH, Funk GF. Factors associated with mortality in 2-year survivors of head and neck cancer. Arch Otolaryngol Head Neck Surg. 2011;137(11):1100–5.PubMedCrossRef
21.
Toll BA, Brandon TH, Gritz ER, Warren GW, Herbst RS. Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement. Clin Cancer Res. 2013;19(8):1941–8.PubMedCrossRef
22.
Jang S, Prizment A, Haddad T, Robien K, Lazovich D. Smoking and quality of life among female survivors of breast, colorectal and endometrial cancers in a prospective cohort study. J Cancer Surviv. 2011;5(2):115–22.PubMedPubMedCentralCrossRef
23.
Weaver KE, Foraker RE, Alfano CM, Rowland JH, Arora NK, Bellizzi KM, et al. Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv. 2013;7(2):253–61.PubMedPubMedCentralCrossRef
24.
25.
Tseng TS, Lin HY, Martin MY, Chen T, Partridge EE. Disparities in smoking and cessation status among cancer survivors and non-cancer individuals: a population-based study from National Health and Nutrition Examination Survey. J Cancer Surviv. 2010;4(4):313–21.PubMedCrossRef
26.
Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368(4):341–50.PubMedCrossRef
27.
Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010;340:b5569.PubMedPubMedCentralCrossRef
28.
29.
Tai E, Buchanan N, Townsend J, Fairley T, Moore A, Richardson LC. Health status of adolescent and young adult cancer survivors. Cancer. 2012;118(19):4884–91.PubMedCrossRef
30.
Underwood JM, Townsend JS, Tai E, White A, Davis SP, Fairley TL. Persistent cigarette smoking and other tobacco use after a tobacco-related cancer diagnosis. J Cancer Surviv. 2012;6(3):333–44.PubMedPubMedCentralCrossRef
31.
32.
Madison K, Schmidt H, Volpp KG. Smoking, obesity, health insurance, and health incentives in the Affordable Care Act. JAMA. 2013;310(2):143–4.PubMedCrossRef
33.
The Staff of The Washington Post. Landmark: the inside story of America’s new health-care law and what it means for us all. New York: Public Affairs; 2010.
34.
35.
36.
Centers for Disease Control and Prevention (CDC). Methodologic changes in the Behavioral Risk Factor Surveillance System in 2011 and potential effects on prevalence estimates. MMWR Morb Mortal Wkly Rep. 2012;61(22):410–3.
37.
38.
Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.PubMedCrossRef
39.
Centers for Disease Control and Prevention (CDC). Vital signs: current cigarette smoking among adults aged ≥18 years—United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(35):1135–40.
40.
Coups EJ, Ostroff JS. A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Prev Med. 2005;40(6):702–11.PubMedCrossRef
41.
42.
Abrams DB. Promise and peril of e-cigarettes: can disruptive technology make cigarettes obsolete? JAMA. 2014;311(2):135–6.PubMedCrossRef
43.
Benowitz NL, Goniewicz ML. The regulatory challenge of electronic cigarettes. JAMA. 2013;310(7):685–6.PubMedCrossRef
44.
Fairchild AL, Bayer R, Colgrove J. The renormalization of smoking? E-cigarettes and the tobacco “endgame”. N Engl J Med. 2014;370(4):293–5.PubMedCrossRef
45.
46.
de Boer AG, Taskila T, Ojajarvi A, van Dijk FJ, Verbeek JH. Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA. 2009;301(7):753–62.PubMedCrossRef
47.
48.
Volpp KG, Galvin R. Reward-based incentives for smoking cessation: how a carrot became a stick. JAMA. 2014;311(9):909–10.PubMedCrossRef
49.
50.
51.
Institute of Medicine and National Research Council. From cancer patient to cancer survivor: lost in transition. Washington, DC: The National Academies Press; 2005.
52.
53.
Warren GW, Marshall JR, Cummings KM, Toll BA, Gritz ER, Hutson A, et al. Addressing tobacco use in patients with cancer: a survey of American Society of Clinical Oncology members. J Oncol Pract. 2013;9(5):258–62.PubMedPubMedCentralCrossRef
54.
Blumenthal KJ, Saulsgiver KA, Norton L, Troxel AB, Anarella JP, Gesten FC, et al. Medicaid incentive programs to encourage healthy behavior show mixed results to date and should be studied and improved. Health Aff (Millwood). 2013;32(3):497–507.CrossRef
55.
Cunningham P. Patient engagement during medical visits and smoking cessation counseling. JAMA Intern Med. 2014;174(8):1291–8.PubMedCrossRef
56.
Berg CJ, Carpenter MJ, Jardin B, Ostroff JS. Harm reduction and cessation efforts and interest in cessation resources among survivors of smoking-related cancers. J Cancer Surviv. 2013;7(1):44–54.PubMedPubMedCentralCrossRef
57.
58.
59.
Blumberg SJ, Luke JV, Cynamon ML. Telephone coverage and health survey estimates: evaluating the need for concern about wireless substitution. Am J Public Health. 2006;96(5):926–31.PubMedPubMedCentralCrossRef
60.
Hu SS, Balluz L, Battaglia MP, Frankel MR. Improving public health surveillance using a dual-frame survey of landline and cell phone numbers. Am J Epidemiol. 2011;173(6):703–11.PubMedCrossRef
Metadata
Title
Health care access and smoking cessation among cancer survivors: implications for the Affordable Care Act and survivorship care
Publication date
01-02-2016
Published in
Journal of Cancer Survivorship / Issue 1/2016
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-015-0446-y

Other articles of this Issue 1/2016

Journal of Cancer Survivorship 1/2016 Go to the issue

Review

Survivorship care plan preferences of cancer survivors and health care providers: a systematic review and quality appraisal of the evidence

OriginalPaper

Pregnancy-associated cardiomyopathy in survivors of childhood cancer

OriginalPaper

Promotion of self-management for post treatment cancer survivors: evaluation of a risk-adapted visit

OriginalPaper

Active transportation in adult survivors of childhood cancer and neighborhood controls

OriginalPaper

Assessing the prevalence of compromised bone health among overweight and obese African-American breast cancer survivors: a case–control study

OriginalPaper

Hanging by a thread: exploring the features of nonresponse in an online young adult cancer survivorship support community
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits